share_log

Usana Health Sciences Analyst Ratings

Benzinga ·  Oct 26, 2023 00:15
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/25/2023 17.13% DA Davidson $62 → $53 Maintains Neutral
04/26/2023 23.76% DA Davidson $52.5 → $56 Maintains Neutral
02/13/2023 16.02% DA Davidson $49 → $52.5 Maintains Neutral
10/27/2022 8.29% DA Davidson $57 → $49 Maintains Neutral
07/28/2022 25.97% DA Davidson $58 → $57 Maintains Neutral
07/12/2022 28.18% DA Davidson $76 → $58 Maintains Neutral
07/07/2022 17.13% Jefferies $78 → $53 Downgrades Hold → Underperform
04/27/2022 67.96% DA Davidson $86 → $76 Maintains Neutral
04/14/2022 90.06% DA Davidson → $86 Initiates Coverage On → Neutral
02/10/2021 178.45% Roth Capital $107 → $126 Maintains Buy
12/17/2020 136.46% Roth Capital → $107 Initiates Coverage On → Buy
08/22/2019 43.65% Jefferies → $65 Initiates Coverage On → Hold
07/03/2019 54.7% Sidoti & Co. $108 → $70 Downgrades Buy → Neutral
04/16/2019 Tigress Financial Initiates Coverage On → Buy

What is the target price for Usana Health Sciences (USNA)?

The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 25, 2023. The analyst firm set a price target for $53.00 expecting USNA to rise to within 12 months (a possible 17.13% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Usana Health Sciences (USNA)?

The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.

When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.

Is the Analyst Rating Usana Health Sciences (USNA) correct?

While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.25, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment